Megan Coder, PharmD, MBA specializes in digital health policy, product assessment, and real-world impact. Her work focuses on enabling decision-makers to evaluate, implement, and scale digital health technologies within and across local and national settings. Previously the Founder and Executive Director of the Digital Therapeutics Alliance (DTA), she is currently serving as Vice President, Board of Directors for the Society for Digital Mental Health (SDMH). Trained as a pharmacist, Megan graduated from the University of Wisconsin—Madison and is currently based in Paris, France.
